Clinical Trial Update: Medication Development in Alcoholism: Investigating Glucocorticoid Antagonists [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating glucocorticoid receptor antagonists for alcohol use disorder has completed. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder

Drugs mentioned

• Glucocorticoid receptor antagonists (glucocorticoid receptor antagonist)

Snippet

Sponsor: The Scripps Research Institute | Conditions: Alcoholism | Phase 2 | Status: COMPLETED | Results posted: 2016-05-19